Add like
Add dislike
Add to saved papers

Reexamining performance validity cutoffs within the Complex Ideational Material and the Boston Naming Test-Short Form using an experimental malingering paradigm.

OBJECTIVE: This study was designed to cross-validate previously published performance validity cutoffs embedded within the Complex Ideational Material (CIM) and the Boston Naming Test-Short Form (BNT-15).

METHOD: Seventy healthy undergraduate students were randomly assigned to either a control condition (n = 40) and instructed to perform to the best of their ability or an experimental malingering (n = 30) condition and instructed to feign cognitive impairment while avoiding detection. All participants were administered the same battery of neuropsychological tests.

RESULTS: Previously published validity cutoffs within the CIM (raw score ≤9 or T-score ≤29) and BNT-15 (≤12) produced good classification accuracy using both experimental malingering and psychometrically defined invalid responding as criterion variable. However, a BNT-15 completion time ≥85 s produced a better signal detection profile than BNT-15 accuracy scores.

CONCLUSIONS: Results support the clinical utility of existing cutoffs. Given the relatively high base rate of failure even in the control group (5-15%), and the perfect specificity of CIM ≤9 and BNT-15 ≤ 11 to noncredible responding, relabeling this range of performance as "Abnormal" instead of "Impaired" would better capture the uncertainty in its clinical interpretation.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app